You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Citation Tools

Article menu
Immunotherapy biomarkers
Original research
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Moutafi MK, Molero M, Martinez Morilla S, et al
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Journal for ImmunoTherapy of Cancer 2022;10:e004757. doi: 10.1136/jitc-2022-004757